Stock listing

Biosergen Ab

Selected listing: 8N10 · FWB · EUR · DE

Biosergen Ab (Frankfurt:8N10), Health Technology. Latest release Jul 24, 2025: Biosergen Appoints Mark Beveridge as Chief Financial Officer.

8N10:FWBEURDEUpdated October 3, 2026
Biosergen Ab logo
Ticker
Frankfurt:8N10
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

Latest news from Biosergen Ab

Biosergen Appoints Mark Beveridge as Chief Financial Officer

July 24, 2025

Biosergen publishes 2024 annual report

April 30, 2025

All Biosergen Ab news →

Research Biosergen Ab

Biosergen Ab company profile

View the public company page for Biosergen Ab on 6ix.

Biosergen Ab news

Read company news and market updates connected to Biosergen Ab.

Biosergen Ab investor events

Find investor webinars, events, and replay context for Biosergen Ab.

Alternate listings

BIOSGN:OMXSTO

SE · SEK

Alternate listing for Biosergen Ab; the primary context on this page is 8N10:FWB.